Literature DB >> 22177881

Improving quality of patient care by improving daily practice in radiation oncology.

Bhishamjit S Chera1, Marianne Jackson, Lukasz M Mazur, Robert Adams, Sha Chang, Kathy Deschesne, Timothy Cullip, Lawrence B Marks.   

Abstract

Radiation oncology is an ever-advancing, complex, technologically based specialty that has been thrust into the public spotlight because of recent reports of serious treatment delivery errors that have impacted the quality of patient care. Although quality assurance (QA) initiatives are already common place in radiation oncology, the continued complex technology and automation-based advances in radiotherapy have created new safety challenges. The ongoing evolution of safety challenges in radiation oncology requires corresponding evolution in workflow and QA programs to ensure the quality of patient care. We believe that the incorporation of QA themes into our daily practice will help to create safer patient environments. Practical QA approaches that can be readily incorporated and applied in the daily practice of radiation oncology include process engineering and human factors engineering, medical peer review, "safety rounds," and software QA tools. Most importantly, we need to develop a culture of safety in which all team members work together to maximize the quality of our patient care.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22177881     DOI: 10.1016/j.semradonc.2011.09.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  8 in total

1.  The importance of accurate treatment planning, delivery, and dose verification.

Authors:  Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2012-03-06

2.  Impact of the introduction of weekly radiotherapy quality assurance meetings at one UK cancer centre.

Authors:  C V Brammer; L Pettit; R Allerton; M Churn; M Joseph; P Koh; I Sayers; M King
Journal:  Br J Radiol       Date:  2014-09-24       Impact factor: 3.039

3.  The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management.

Authors:  M Saiful Huq; Benedick A Fraass; Peter B Dunscombe; John P Gibbons; Geoffrey S Ibbott; Arno J Mundt; Sasa Mutic; Jatinder R Palta; Frank Rath; Bruce R Thomadsen; Jeffrey F Williamson; Ellen D Yorke
Journal:  Med Phys       Date:  2016-07       Impact factor: 4.071

4.  Local consolidative therapy for oligometastatic non-small cell lung cancer.

Authors:  Pamela P Samson; Matthew B Spraker; Shahed N Badiyan; Gregory Vlacich; Clifford G Robinson; Aadel A Chaudhuri
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

5.  Clinical practice workflow in Radiation Oncology should be highly standardized.

Authors:  Per Halvorsen; Nilendu Gupta; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2019-03-12       Impact factor: 2.102

6.  Implementing and integrating a clinically driven electronic medical record for radiation oncology in a large medical enterprise.

Authors:  John P Kirkpatrick; Kim L Light; Robyn M Walker; Debra L Georgas; Phillip A Antoine; Robert W Clough; Heidi B Cozart; Fang-Fang Yin; Sua Yoo; Christopher G Willett
Journal:  Front Oncol       Date:  2013-04-18       Impact factor: 6.244

7.  What is the degree of innovation routinely implemented in Dutch radiotherapy centres? A multicentre cross-sectional study.

Authors:  Maria Jacobs; Liesbeth Boersma; Andre Dekker; Geert Bosmans; Frits van Merode; Frank Verhaegen; Dirk de Ruysscher; Rachelle Swart; Cindy Kengen; Philippe Lambin
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

8.  Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago.

Authors:  Anis Ahmad; Lakshmi Santanam; Abhishek A Solanki; Laura Padilla; Erina Vlashi; Patrizia Guerrieri; Michael M Dominello; Jay Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2020-11-24       Impact factor: 2.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.